LIGAND
Live / Applied — Second extension granted (statement of use) (as of 11 Nov 2025)
What this means for you
Not registered yet, but its 11 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98353663
- Mark type
- Stylized text
- Filed
- 11 Jan 2024
- Published for opposition
- 24 Sept 2024
- Attorney of record
- Gazal Pour-Moezzi
Goods and services
- Class 001 — Chemicals: Solubilizing chemical agents for use in the manufacture of pharmaceutical preparations; Solubilizing chemical agents for use in diagnostic research
- Class 005 — Pharmaceuticals: Antivirals
Owner
- Ligand Pharmaceuticals Incorporated, Jupiter, FL, US
- Ligand Pharmaceuticals Incorporated, San Diego, CA, US
Prior registrations
Prosecution history
- 12 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Nov 2025 — SOU EXTENSION 2 GRANTED
- 11 Nov 2025 — SOU EXTENSION 2 FILED
- 11 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Aug 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 26 Aug 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 May 2025 — SOU EXTENSION 1 GRANTED
- 14 May 2025 — SOU EXTENSION 1 FILED
- 14 May 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED